Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 4, 2014, Pages 1415-1426

  Song, Fanglong ^a   Tang, Jilei ^a   Geng, Rui ^a   Hu, Hansheng ^a   Zhu, Chunhui ^a   Cui, Weiding ^a   Fan, Weimin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow mononuclear cells; Mesenchymal stem cells; OA; Sheep; Treatment

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; COLLAGENASE 3;

ANIMAL; ANTERIOR CRUCIATE LIGAMENT; BIOLOGICAL THERAPY; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; OSTEOARTHRITIS, KNEE; PROCEDURES; SHEEP; TREATMENT OUTCOME;

AGGRECANS; ANIMALS; ANTERIOR CRUCIATE LIGAMENT; BONE MARROW TRANSPLANTATION; CELL- AND TISSUE-BASED THERAPY; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; MATRIX METALLOPROTEINASE 13; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOARTHRITIS, KNEE; SHEEP; TREATMENT OUTCOME;

EID: 84899530170     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Schaap LA, Peeters GM, Dennison EM, Zambon S, Nikolaus T, Sanchez-Martinez M, Musacchio E, van Schoor NM and Deeg DJ. European Project on OSteoArthritis (EPOSA): methodological challenges in harmonization of existing data from five European population-based cohorts on aging. BMC Musculoskelet Disord 2011; 12: 272.
2. Harvey WF and Hunter DJ. The role of analgesics and intra-articular injections in disease management. Rheum Dis Clin North Am 2008; 34: 777-788.
3. Qi Y, Feng G and Yan W. Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep 2012; 39: 5683-5689.
4. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
5. Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T and Toda K. Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc 2006; 14: 1307-1314.
6. Koelling S and Miosge N. Stem cell therapy for cartilage regeneration in osteoarthritis. Expert Opin Biol Ther 2009; 9: 1399-1405.
7. Attur M, Samuels J, Krasnokutsky S and Abramson SB. Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?. Best Pract Res Clin Rheumatol 2010; 24: 71-79.
8. Murphy JM, Fink DJ, Hunziker EB and Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48: 3464-3474.
9. Maumus M, Guerit D, Toupet K, Jorgensen C and Noel D. Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res Ther 2011; 2: 14.
10. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M and Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 2008; 11: 343-353.
11. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N and Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002; 10: 199-206.
12. Cardoso MM, Franco EC, de Souza CC, Da SM, Gouveia A and Gomes-Leal W. Minocycline treatment and bone marrow mononuclear cell transplantation after endothelin-1 induced striatal ischemia. Inflammation 2013; 36: 197-205.
13. Baikova YP, Fatkhudinov T, Bol'Shakova GB, Bukharova TB, Slashcheva GA, Khokhlova OV, Murashev AN and Gol'Dshtein DV. Reparation of the myocardium after transplantation of mononuclear bone marrow cells. Bull Exp Biol Med 2011; 150: 522-529.
14. Ozdemir M, Attar A, Kuzu I, Ayten M, Ozgencil E, Bozkurt M, Dalva K, Uckan D, Kilic E, Sancak T, Kanpolat Y and Beksac M. Stem cell therapy in spinal cord injury: in vivo and postmortem tracking of bone marrow mononuclear or mesenchymal stem cells. Stem Cell Rev 2012; 8: 953-962.
15. Takami T, Terai S and Sakaida I. Advanced therapies using autologous bone marrow cells for chronic liver disease. Discov Med 2012; 14: 7-12.
16. Wang BL, Sun W, Shi ZC, Zhang NF, Yue DB, Guo WS, Xu SQ, Lou JN and Li ZR. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 2010; 130: 859-865.
17. Williams IR and Brophy RH. Cartilage repair procedures: clinical approach and decision making. Instr Course Lect 2008; 57: 553-561.
18. Armstrong S, Read R and Ghosh P. The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol 1994; 21: 680-688.
19. Farndale RW, Buttle DJ and Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986; 883: 173-177.
20. Greish S, Abogresha N, Abdel-Hady Z, Zakaria E, Ghaly M and Hefny M. Human umbilical cord mesenchymal stem cells as treatment of adjuvant rheumatoid arthritis in a rat model. World J Stem Cells 2012; 4: 101-109.
21. Feitosa ML, Fadel L, Beltrao-Braga PC, Wenceslau CV, Kerkis I, Kerkis A, Birgel JE, Martins JF, Martins DS, Miglino MA and Ambrosio CE. Successful transplant of mesenchymal stem cells in induced osteonecrosis of the ovine femoral head: preliminary results. Acta Cir Bras 2010; 25: 416-422.
22. Vasconcelos-dos-Santos A, Rosado-de-Castro PH, Lopes DSS, Da CSJ, Ramos AB, Rodriguez DFG, Barbosa DFL, Gutfilen B and Mendez-Otero R. Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: Is there a difference in biodistribution and efficacy?. Stem Cell Res 2012; 9: 1-8.
23. Jiang W, Ma A, Wang T, Han K, Liu Y, Zhang Y, Dong A, Du Y, Huang X, Wang J, Lei X and Zheng X. Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflugers Arch 2006; 453: 43-52.
24. Horie M, Choi H, Lee RH, Reger RL, Ylostalo J, Muneta T, Sekiya I and Prockop DJ. Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that enhances expression of type II collagen. Osteoarthritis Cartilage 2012; 20: 1197-1207.
25. Maltman DJ, Hardy SA and Przyborski SA. Role of mesenchymal stem cells in neurogenesis and nervous system repair. Neurochem Int 2011, 59: 347-356.
26. Takahashi M, Li TS, Suzuki R, Kobayashi T, Ito H, Ikeda Y, Matsuzaki M and Hamano K. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 2006; 291: H886-H893.
27. Caplan AI and Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084.
28. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM and McIlwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009; 27: 1675-1680.
29. Fernandes JC, Martel-Pelletier J and Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39: 237-246.
30. Chen FH and Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008, 10: 223.
31. Plaas A, Velasco J, Gorski DJ, Li J, Cole A, Christopherson K and Sandy JD. The relationship between fibrogenic TGFbeta1 signaling in the joint and cartilage degradation in post-injury osteoarthritis. Osteoarthritis Cartilage 2011; 19: 1081-1090.
32. Centeno CJ, Kisiday J, Freeman M and Schultz JR. Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: A case study. Pain Physician 2006; 9: 253-256.
33. Slynarski K, Deszczynski J and Karpinski J. Fresh bone marrow and periosteum transplantation for cartilage defects of the knee. Transplant Proc 2006; 38: 318-319.
34. Soltan M, Smiler D and Choi JH. Bone marrow: orchestrated cells, cytokines, and growth factors for bone regeneration. Implant Dent 2009; 18: 132-141.
35. Lei SH, Guo L, Yue HY, Zhao DC, Zhang CJ, Du WJ, Huang LZ, Wang J, Dang YX, Liu JS, Hao JL and Wang YL. Marrow stromal stem cell autologous transplantation in denervated fracture healing: an experimental study in rats. Orthop Surg 2013; 5: 280-288.
36. Mokbel AN, El TO, Shamaa AA, Rashed LA, Sabry D and El SA. Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord 2011; 12: 259.
37. Veronesi F, Giavaresi G, Tschon M, Borsari V, Nicoli AN and Fini M. Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease. Stem Cells Dev 2013; 22: 181-192.
38. Friedenstein AJ, Chailakhyan RK and Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987; 20: 263-272.
39. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
40. Wise JK, Alford AI, Goldstein SA and Stegemann JP. Comparison of Uncultured Marrow Mononuclear Cells and Culture-Expanded Mesenchymal Stem Cells in 3D Collagen-Chitosan Microbeads for Orthopedic Tissue Engineering. Tissue Eng Part A 2014; 20: 210-24.
41. Boquest AC, Shahdadfar A, Fronsdal K, Sigurjonsson O, Tunheim SH, Collas P and Brinchmann JE. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 2005; 16: 1131-1141.
42. Boiret N, Rapatel C, Veyrat-Masson R, Guillouard L, Guerin JJ, Pigeon P, Descamps S, Boisgard S and Berger MG. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol 2005; 33: 219-225.
43. Boos AM, Loew JS, Deschler G, Arkudas A, Bleiziffer O, Gulle H, Dragu A, Kneser U, Horch RE and Beier JP. Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model. J Cell Mol Med 2011; 15: 1364-1378.
44. Modder UI, Roforth MM, Nicks KM, Peterson JM, McCready LK, Monroe DG and Khosla S. Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection. Bone 2012; 50: 804-810.
45. Qian H, Le Blanc K and Sigvardsson M. Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein. J Biol Chem 2012; 287: 25795-25807.
46. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R and Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 2000; 28: 707-715.
47. Mendes SC, Tibbe JM, Veenhof M, Bakker K, Both S, Platenburg PP, Oner FC, de Bruijn JD and van Blitterswijk CA. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 2002; 8: 911-920.
48. Alves H, Munoz-Najar U, De Wit J, Renard AJ, Hoeijmakers JH, Sedivy JM, Van Blitterswijk C and De Boer J. A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells. J Cell Mol Med 2010; 14: 2729-2738.
49. Veronesi F, Torricelli P, Borsari V, Tschon M, Rimondini L and Fini M. Mesenchymal stem cells in the aging and osteoporotic population. Crit Rev Eukaryot Gene Expr 2011; 21: 363-377.
50. Stolzing A, Jones E, McGonagle D and Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008; 129: 163-173.
51. Giannini S, Buda R, Vannini F, Cavallo M and Grigolo B. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res 2009; 467: 3307-3320.